|
2024
|
Invention
|
Stabilized lipid and lipidoid nanoparticle formulations with specific surfactant properties for e... |
|
|
Invention
|
Non-systemic mrna administration. The present invention relates to compositions designed for loca... |
|
|
Invention
|
Compositions for introducing rna into cells.
The present invention relates to oligomers, polymer... |
|
|
Invention
|
Gm-csf-encoding nucleic acids, pharmaceutical compositions, methods and uses thereof. Described a... |
|
|
G/S
|
Preservatives for pharmaceuticals; chemicals for use in industry and science; chemical substances... |
|
|
G/S
|
Preservatives for pharmaceuticals; chemicals for use in
industry and science; chemical substance... |
|
2023
|
Invention
|
Regulator(s) of energy homeostasis-encoding rna molecule(s) with increased translation efficiency... |
|
|
Invention
|
Stable lipid or lipidoid nanoparticle suspensions. Provided are stabilized lipid nanoparticle (LN... |
|
|
G/S
|
Preservatives for pharmaceuticals; Chemical substances, chemical materials and chemical preparati... |
|
2022
|
Invention
|
Cftr mrna compositions and related methods and uses.
Materials, formulations, production methods... |
|
|
Invention
|
Minimal utr sequences. Described are DNA molecules which can be transcribed into an mRNA harbouri... |
|
|
Invention
|
Formulations for aerosol formation and aerosols for the delivery of nucleic acid.
The invention ... |
|
|
Invention
|
Formulations for aerosol formation and aerosols for the delivery of nucleic acid. The invention r... |
|
2021
|
Invention
|
Use of ifn-lambda mrna for treating viral infections.
The present invention relates to pharmaceu... |
|
|
Invention
|
Use of ifn-lambda mrna for treating viral infections. The present invention relates to pharmaceut... |
|
|
Invention
|
Pulmonary delivery of mrna to non-lung target cells.
Compositions comprising mRNA formulated for... |
|
2020
|
Invention
|
Rna with a combination of unmodified and modified nucleotides for protein expression.
The invent... |
|
|
Invention
|
Treatment of ciliopathies.
The present disclosure provides a pharmaceutical composition comprisi... |
|
|
Invention
|
Treatment of ciliopathies. The present disclosure provides a pharmaceutical composition com... |
|
|
Invention
|
Treatment of ciliopathies. The present disclosure provides a pharmaceutical composition comprisin... |
|
|
Invention
|
Mrna purification by tangential flow filtration.
The present disclosure provides a method of pur... |
|
|
Invention
|
Mrna purification by tangential flow filtration. The present disclosure provides a method of puri... |
|
2019
|
Invention
|
Plasmid containing a sequence encoding an mrna with a segmented poly(a) tail.
The present disclo... |
|
|
Invention
|
Plasmid containing a sequence encoding an mrna with a segmented poly(a) tail. The present disclos... |
|
|
Invention
|
Cftr mrna compositions and related methods and uses. The present disclosure relates to materials,... |
|
|
Invention
|
Lipid-based formulations containing salts for the delivery of rna.
The invention provides a comp... |
|
|
Invention
|
Lipid-based formulations containing salts for the delivery of rna. The invention provides a compo... |
|
|
Invention
|
Rna for use in the treatment of ligament or tendon lesions. Described is a liquid composition con... |
|
|
Invention
|
Cryoprotective agents for particulate formulations.
Provided is a composition comprising (i) a n... |
|
|
Invention
|
Lipid-based formulations for the delivery of rna.
The invention provides a composition which is ... |
|
|
Invention
|
Lipid-based formulations for the delivery of rna. The invention provides a composition which is s... |
|
|
Invention
|
Cryoprotective agents for particulate formulations. Provided is a composition comprising (i) a na... |
|
|
Invention
|
Polyribonucleotide containing deuterated nucleotides.
The present disclosure provides polyribonu... |
|
|
Invention
|
Polyribonucleotide containing deuterated nucleotides. The present disclosure provides polyribonuc... |
|
|
Invention
|
Pulmonary delivery of mrna to non-lung target cells. Compositions comprising mRNA formulated for ... |
|
2018
|
Invention
|
Conjugate with target-finding ligand and use thereof. Described is a conjugate of agent complex a... |
|
2017
|
Invention
|
Ornithine transcarbamylase coding polyribonucleotides and formulations thereof. In certain aspect... |
|
|
Invention
|
Cas9 mrnas. In certain aspects, the disclosure relates to compositions comprising modified Cas9 p... |
|
|
Invention
|
Novel minimal utr sequences. Described are DNA molecules which can be transcribed into an mRNA ha... |
|
2016
|
Invention
|
Utrs increasing the translation efficiency of rna molecules. Described is an RNA molecule compris... |
|
|
Invention
|
Atp-binding cassette family coding polyribonucleotides and formulations thereof. Polynucleotides ... |
|
2015
|
Invention
|
Compositions for introducing nucelic acid into cells. The present invention relates to polymers c... |
|
|
Invention
|
Induction of osteogenesis by delivering bmp encoding rna. The present invention relates to a phar... |
